| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $110.5M | +13.2% |
| Cost of Revenue | $70.6M | +66.3% |
| Gross Profit | $39.9M | -37.0% |
| R&D Expense | $29.2M | -25.0% |
| SG&A Expense | $49.7M | +17.1% |
| Operating Income | -$68.7M | -53.9% |
| Interest Expense | $20.4M | +6.9% |
| Pre-tax Income | -$102.7M | -60.7% |
| Income Tax | $159K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.2M | -34.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $11.9M | +20.3% |
| Current Assets | $92.2M | +32.9% |
| Total Assets | $193.6M | -21.6% |
| Current Liabilities | $151.6M | +264.9% |
| Long-term Debt | $103.1M | -16.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.5M | +21.9% |
| Capital Expenditures | $26.6M | -11.5% |
| Investing Cash Flow | -$14.2M | +19.4% |
| Financing Cash Flow | $19.0M | -20.5% |
| Free Cash Flow | -$45.0M | +16.1% |
| +120.8% |
| Net Income | -$102.8M | -60.8% |
| EPS (Basic) | -$4.26 | -30.3% |
| EPS (Diluted) | -$4.26 | -30.3% |
| Total Liabilities |
| $205.3M |
| +16.4% |
| Stockholders' Equity | -$11.7M | -116.6% |